eli lilly glp 1 agonist Orforglipron: Lilly's New Oral GLP-1 Weight-loss Pill Medscape | Orforglipron, Eli Lilly's

Gastrointestinal modulation: The medication slows gastric emptying meaning food stays in the stomach longer leading to prolonged fullness and reduced meal frequency

It's released when you eat and tells your body to make insulin to control your blood sugar

Researchers are currently trying to pin down the biomarker signatures that indicate if a person will respond well to GLP-1 RAs

Curcumin Improves Glucose Tolerance via Stimulation of Glucagon-like Peptide-1 Secretion. Molecular Nutrition & Food Research, vol

"A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes"

Most of the studies evaluated the cardiovascular outcomes using a composite outcome of major adverse cardiac events (MACE) or one of its components, cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke